Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01120249
Title S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery (S0931)
Acronym S0931
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors SWOG Cancer Research Network
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.